heart failure

Krolevets M, Cate VT, Prochaska JH, Schulz A, Rapp S, Zeid S, Tenzer S, Andrade-Navarro MA, Lu A, Strauch K, Schuster AK, Beutel ME, Heinrich[...]

Marvasti TB, Murray KR, Ho G, Lowes H, Kozuszko S, Brum M, Verhoeff N, Fan CPS, Udell JA, Hershman SG, Januzzi JL, Sandhu AT, Ross[...]

Sandhu AT, Furst A, Rodriguez F, Kalwani N, Maron DJ, Nallamshetty S, Din N, Fan M, Khachatourian K, Skaar JR, Tonnu-Mihara I. Trends in post-discharge[...]

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]

Waqas SA, Ibrahim M, Ahmed M, Waqas M, Aamir J, Fudim M, Musani MH, Fonarow GC, Greene SJ. Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists[...]

Sato N, Okami S, Yoshikawa-Ryan K, Yamashita S, Kobayashi R, Arita Y, Kim SW, Knapp R, Holl K, Fonarow GC. Pharmacological treatments and clinical events[...]

Shiraishi Y, Nakamaru R, Kohsaka S, Sandhu AT, Heidenreich PA, Ikemura N, Sawano M, Niimi N, Kimura T, Katsumata Y, Nishiyama T, Ueda I, Takatsuki[...]

Goel K, Lindman BR, Schwartz A, Cohen DJ, Giustino G, Oldemeyer JB, Strote J, Babaliaros V, Devireddy CM, Fischbein MP, Fearon WF, Daniels D, Spies[...]

Sandhu AT, Vasti E. 12 Is the New 23: Health Status Assessment in Heart Failure Trials. J Am Coll Cardiol. 2026 May 20:S0735-1097(26)06202-9. doi: 10.1016/j.jacc.2026.03.162.[...]

Brownell N, Solomon N, Greene SJ, Chiswell K, Vaduganathan M, Yancy C, Hsue P, Ziaeian B, Fonarow GC. Clinical Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among[...]